WCM Investment Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-26,997
| Closed | -$2.72M | – | 218 |
|
|
2021
Q3 | $2.72M | Buy |
26,997
+421
| +2% | +$42.4K | 0.01% | 163 |
|
|
2021
Q2 | $3.76M | Sell |
26,576
-14,383
| -35% | -$2.04M | 0.01% | 146 |
|
|
2021
Q1 | $4.08M | Buy |
40,959
+14,647
| +56% | +$1.46M | 0.01% | 142 |
|
|
2020
Q4 | $3.25M | Buy |
26,312
+116
| +0.4% | +$14.3K | 0.01% | 153 |
|
|
2020
Q3 | $2.55M | Buy |
26,196
+1,541
| +6% | +$150K | 0.01% | 152 |
|
|
2020
Q2 | $3.85M | Buy |
24,655
+12,773
| +107% | +$1.99M | 0.01% | 139 |
|
|
2020
Q1 | $1.72M | Buy |
11,882
+3,463
| +41% | +$500K | 0.01% | 152 |
|
|
2019
Q4 | $1.72M | Buy |
8,419
+2,110
| +33% | +$431K | 0.01% | 147 |
|
|
2019
Q3 | $507K | Sell |
6,309
-2,220
| -26% | -$178K | ﹤0.01% | 142 |
|
|
2019
Q2 | $804K | Sell |
8,529
-273
| -3% | -$25.7K | 0.01% | 134 |
|
|
2019
Q1 | $752K | Buy |
+8,802
| New | +$752K | 0.01% | 128 |
|